Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Laszlo J. Wagner"'
Autor:
Judit Hodrea, Adar Saeed, Agnes Molnar, Attila Fintha, Adrienn Barczi, Laszlo J. Wagner, Attila J. Szabo, Andrea Fekete, Dora B. Balogh
Publikováno v:
PLoS ONE, Vol 17, Iss 2 (2022)
Introduction Cardiovascular disease (CVD) is two to five times more prevalent in diabetic patients and is the leading cause of death. Therefore, identification of novel therapeutic strategies that reduce the risk of CVD is a research priority. Clinic
Externí odkaz:
https://doaj.org/article/b7f2028536634ea6b025f8a427402667
Autor:
Judit Hodrea, Adar Saeed, Agnes Molnar, Attila Fintha, Adrienn Barczi, Laszlo J. Wagner, Attila J. Szabo, Andrea Fekete, Dora B. Balogh
Publikováno v:
PloS one. 17(2)
Introduction Cardiovascular disease (CVD) is two to five times more prevalent in diabetic patients and is the leading cause of death. Therefore, identification of novel therapeutic strategies that reduce the risk of CVD is a research priority. Clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d293983ab913fce174aa8d41e0f47a7c
https://pubmed.ncbi.nlm.nih.gov/35176041
https://pubmed.ncbi.nlm.nih.gov/35176041
Autor:
Nora F Banki, Agota Ver, Laszlo J Wagner, Adam Vannay, Peter Degrell, Agnes Prokai, Renata Gellai, Lilla Lenart, Dorottya-Nagy Szakal, Eva Kenesei, Klara Rosta, Gyorgy Reusz, Attila J Szabo, Tivadar Tulassay, Chris Baylis, Andrea Fekete
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39938 (2012)
Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) are the standard clinical therapy of diabetic nephropathy (DN), while aldosterone antagonists are only used as adjuncts. Previously in experimental DN we showe
Externí odkaz:
https://doaj.org/article/55fac4f66f30444e93b047ed38ee9f7c
Autor:
Dorina Supák, Balázs Mészáros, Márta Nagy, Dániel Gáspár, László J. Wagner, Zoltán Kukor, Sándor Valent
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Patients facing severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infections with comorbidities, especially patients whose immune system is weakened have higher chances to face severe outcomes. One of the main reasons behind the suppressio
Externí odkaz:
https://doaj.org/article/e22488ec53974fceaa00111834653344